Trials / Completed
CompletedNCT01802723
Dose Ranging Study
A Dose Ranging Study of the Safety and Efficacy of LIPO-202 Healthy Patients With Subcutaneous Fat in the Periumbilical Area
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 472 (actual)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Dose Ranging Study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drug: salmeterol xinafoate | |
| DRUG | Drug: Placebo |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-10-01
- First posted
- 2013-03-01
- Last updated
- 2015-03-26
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01802723. Inclusion in this directory is not an endorsement.